Evidence map›Paper›PMID 39169975›Full record

ArticleGerms2024

Petros Ioannou, Sofia Maraki, Emmanuel Velivasakis, Diamantis P Kofteridis

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Germs, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Petros IoannouMD, MSc, PhD, Internal Medicine Department, University Hospital of Heraklion, Heraklion, PC 71110, Greece, and School of Medicine, University of Crete, Heraklion, PC 71003, Greece.
Sofia MarakiMD, PhD, Microbiology Department, University Hospital of Heraklion, Heraklion, PC 71110, Greece.
Emmanuel VelivasakisMD, Orthopedics Department, University Hospital of Heraklion, Heraklion, PC 71110, Greece.
Diamantis P KofteridisMD, PhD, Internal Medicine Department, University Hospital of Heraklion, Heraklion, PC 71110, Greece, and School of Medicine, University of Crete, Heraklion, PC 71003, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Case report: A 39-year-old woman with a history of glucose-6-phosphate dehydrogenase deficiency and multiple surgeries at the left lower extremity for osteomyelitis at the left tibia presented with a relapse of chronic osteomyelitis of the left tibia. She underwent surgical debridement, and cultures grew Conclusions: Accurate identification by advanced diagnostic techniques is essential for effectively managing rare pathogens. Further research and reporting of cases are needed to understand better the epidemiology, pathogenesis, optimal treatment, and improved clinical outcomes associated with

Indexed as

Arthrobacter cumminsiiosteomyelitispolymicrobial infectionPseudoglutamicibacter cumminsii

Identifiers

PMID39169975
PMCPMC11333835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.